Delivery Order SPE2DB24D1205-SPE2DB25FCYEX
Award Date
7/2/25
Potential Completion Date
7/24/25
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,241.86 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a period of performance through June 5, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,862.79 and an ultimate completion date of June 13, 2025. The contract provides for the delivery of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $13,862.79 and a period of performance ending on July 16, 2025. The contract is not a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a firm fixed price ceiling value of $13,862.79 and a period of performance through June 9, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a medication, with a ceiling value of $13,862.79 and a period of performance through June 4, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,862.79 and a performance period through May 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $9,241.86 and a completion date of July 15, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corporation for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and an ultimate completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of its ongoing efforts to provide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $27,725.58 and a period of performance through July 21, 2025. The contract is not designated as a set-aside and appears to be open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $14,441.87 and is a Firm Fixed Price arrangement with a completion date of June 2, 2023. The contract was awarded on May 11, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System...